Spatially resolved single cell atlas deciphers SAA1 inflammatory epithelial cells
Yajie Wu , Zhifei Su , Bowen Zhang , Fangjie Zhou , Ranhui Xi , Xian Peng , Yuqing Li , Lin Yue , Xiaoyan Wang , Feng Chen , Yao Lu , Xuedong Zhou , Biao Ren , Jiyao Li
International Journal of Oral Science ›› 2026, Vol. 18 ›› Issue (1) : 65
Disruption of epithelial integrity is a pivotal event in inflammation, disease pathogenesis, and tissue homeostasis. To investigate these processes in chronic inflammatory disease, we performed spatial transcriptomics integrated with single-cell RNA sequencing (scRNA-seq) on human gingival tissue, coupled with metagenomic analysis of matched subgingival plaque. This approach allowed in situ characterization of epithelial heterogeneity and microbiome-epithelium-connective tissue crosstalk. We identified a distinct inflammatory epithelial subpopulation (SAA1+Epi), situated within the junctional epithelium, that becomes activated through the TLR2-PITX2 axis by Porphyromonas gingivalis lipopolysaccharide. These SAA1+Epi cells secrete TGFβ, which induces an inflammatory program in the connective tissue by driving the differentiation of inflammation-associated fibroblasts (C3+FB) via the PI3K/Akt pathway. Concurrently, SAA1+Epi cells express chemotactic factors such as CXCL6 to recruit NK cells, thereby sustaining the inflammatory niche. The transcription factor PITX2 emerged as a critical regulator of SAA1+Epi differentiation; targeting PITX2 suppressed C3+FB induction and natural killer (NK) cells recruitment, ultimately attenuating periodontitis progression. Our findings position SAA1+Epi as a frontline responder to dysbiotic bacteria at the inflammatory interface and underscore its essential role in regulating epithelial-connective tissue homeostasis during inflammation.
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
Disease, G. B. D., Injury & Risk Factor, C. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet406, 1873–1922 (2025). |
| [12] |
|
| [13] |
Bashir NZ, Woolf BAR, Burgess S, Bernabé E. Periodontitis and Systemic Disease: The Impact of Covariate Selection. J. Dent. Res. 105, 59–66 (2026). |
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
Zhang, H. et al. Interfacial coordination-engineered emulgel modulates the osteo-immune microenvironment in periodontitis treatment Via HIF1 signaling pathway-induced metabolic reprogramming. Adv Sci (Weinh). 12, e09998 (2025). |
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
Sakthivel, K. et al. Integrin-Piezo1 axis drives ECM remodeling and invasion of 3D breast epithelium. Adv. Sci (Weinh).13, e09932 (2026). |
| [43] |
|
| [44] |
Caetano, A. J. et al. Defining human mesenchymal and epithelial heterogeneity in response to oral inflammatory disease. eLife10, e62810 (2021). |
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
Brozek, R., Lorenz, A., Dorocka-Bobkowska, B. & Kurpisz, M. Immunoinflammatory response in periodontal diseases. J. Physiol. Pharmacol.76, 10.26402/jpp.2025.3.02 (2025). |
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
Sisto, M., Ribatti, D. & Lisi, S. Organ fibrosis and autoimmunity: the role of inflammation in TGFbeta-dependent EMT. Biomolecules11, 310 (2021). |
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
The Author(s)
/
| 〈 |
|
〉 |